Literature DB >> 19083254

Age-related efficacy with an AAV vector in Fabry disease mice.

Dwight D Koeberl1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 19083254     DOI： 10.1016/j.ymgme.2008.10.014

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN： 1096-7192            Impact factor:   4.797


× No keyword cloud information.
  3 in total

1.  Preclinical dose-finding study with a liver-tropic, recombinant AAV-2/8 vector in the mouse model of galactosialidosis.

Authors:  Huimin Hu; Elida Gomero; Erik Bonten; John T Gray; Jim Allay; Yanan Wu; Jianrong Wu; Christopher Calabrese; Arthur Nienhuis; Alessandra d'Azzo
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

Review 2.  Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.

Authors:  Shannon L Macauley
Journal:  Pediatr Endocrinol Rev       Date:  2016-06

Review 3.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.